Cumberland Pharmaceuticals, Inc. (CPIX) Misses Q4 EPS by 1c

Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) reported Q4 EPS of $0.04, $0.01 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $13 million versus the consensus estimate of $12.97 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals, Inc. (CPIX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Limoneira sells vineyard property for $15M at public auction
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance